Press Release, 7 June 2023
Scandinavian Real Heart AB announces today that board member Patrick NJ Schnegelsberg at his own request resigns from the Company's board. Schnegelsberg's last day will be today, June 7, 2023.
Patrick NJ Schnegelsberg has after careful consideration taken the decision to resign from the board of directors of Realheart, as his work situation requires his undivided attention and time.
“On behalf of the Board, the Company and the shareholders, I would like to thank Patrick for his contribution and commitment to the Board”, says Christer Norström, Chairman of the Board of Realheart.
The nomination committee will begin the work of finding a replacement for Patrick NJ Schnegelsberg.
For more information please contact:
Ina Laura Perkins, CEO
Phone: +46(0)70 406 49 21
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart® TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation. A unique concept in the medical technology world.Board Member in Realheart Resigns at his own Request (PDF)